chronic conditions Archives

Big Pharma Profits by Keeping Us Sick: The Truth Behind Chronic Treatments

Brian RogersJune 13, 20240186 views

Pharmaceutical companies operate on business models that emphasize continuous revenue streams, particularly through the treatment of chronic conditions like diabetes, hypertension, and high cholesterol. This approach contrasts sharply with the one-time profit from a cure. While treatments for diseases such as HIV and cancer generate ongoing revenue, the development and prioritization of cures face numerous economic and regulatory hurdles. Critics argue that Big Pharma’s focus on profit leads to the suppression of potential cures, and regulatory bodies and market control entities, like LegitScript, often act to maintain this status quo. This article examines the inherent economic incentives in the pharmaceutical industry that prioritize treatments over cures, the suppression of natural remedies, and the broader implications for global health.

American Policy Failures: The Blocking of Affordable Medications from Abroad

Brian RogersJune 4, 20240117 views

The debate over healthcare and drug prices in the United States highlights significant socio-economic disparities. Higher-income individuals often oppose universal healthcare due to concerns over financial responsibility, while lower-income communities and minorities face substantial barriers to accessing healthcare and healthy food, exacerbating chronic health conditions. High medication costs lead to non-adherence, particularly among those with lower incomes and seniors, resulting in unmanaged health issues and increased hospitalizations. Addressing these disparities requires recognizing the broader socio-economic factors and implementing policies that ensure equitable access to healthcare and medications for all Americans.

Systemic Racism in Healthcare: The Cost of High Drug Prices for Communities of Color

Brian RogersJune 4, 20240132 views

The rising cost of prescription drugs in the United States disproportionately impacts Latino, Black, and immigrant communities, exacerbating existing health disparities. These groups, facing higher rates of chronic conditions and economic barriers, often struggle with affordability and access to necessary medications. Economic instability and lack of insurance further complicate their healthcare access, leading to unmanaged health conditions and increased hospitalizations. Addressing this issue requires comprehensive policy changes, such as allowing Medicare to negotiate drug prices and increasing funding for community health centers, to ensure equitable access to affordable healthcare for all.